Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Tavist (Clemastine Fumarate) Tablet, 2.68 Milligrams

TitleDrug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Tavist (Clemastine Fumarate) Tablet, 2.68 Milligrams
ToC Doc Tavist (Clemastine Fumarate) Tablet, 2.68 Milligrams
Docket Number2024-24103
Type Notice
Subject Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness:
Tavist (Clemastine Fumarate) Tablet, 2.68 Milligrams
Publication Date2024-10-18
Last Updated Date 2024-10-17 08:19:19 -0400
Last Public Inspection2024-10-17
Filed At2024-10-17T08:45:00.000-04:00
PDF 2024-24103_PI.pdf (93633 bytes)
Download TXT / HTML / JSON
Number of Pages 3
Filing Typeregular
AgenciesFood and Drug Administration

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021